Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses
IntroductionAn effective vaccination policy must be implemented to prevent foot-and-mouth disease (FMD). However, the currently used vaccines for FMD have several limitations, including induction of humoral rather than cellular immune responses.MethodsTo overcome these shortcomings, we assessed the...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1493561/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841555105534443520 |
---|---|
author | Gang Sik Kim Dong Yun Kwak Hyeong Won Kim Seokwon Shin Mi-Kyeong Ko Seong Yun Hwang So Hui Park Dong Hyeon Kim Jong-Hyeon Park Su-Mi Kim Min Ja Lee |
author_facet | Gang Sik Kim Dong Yun Kwak Hyeong Won Kim Seokwon Shin Mi-Kyeong Ko Seong Yun Hwang So Hui Park Dong Hyeon Kim Jong-Hyeon Park Su-Mi Kim Min Ja Lee |
author_sort | Gang Sik Kim |
collection | DOAJ |
description | IntroductionAn effective vaccination policy must be implemented to prevent foot-and-mouth disease (FMD). However, the currently used vaccines for FMD have several limitations, including induction of humoral rather than cellular immune responses.MethodsTo overcome these shortcomings, we assessed the efficacy of levamisole, a small-molecule immunomodulator, as an adjuvant for the FMD vaccine. We conducted in vitro studies using murine peritoneal exudate cells (PECs) and porcine peripheral blood mononuclear cells (PBMCs) and in vivo studies using mice (experimental animals) and pigs (target animals). We evaluated levamisole-mediated modulation of the innate and adaptive immune responses; early, mid-term, and long-term immune-inducing effects; modes of action; and host defense against viral infection.ResultsLevamisole treatment promoted IFNγ secretion in murine PECs and porcine PBMCs. Additionally, it induced robust and long-lasting immune responses by eliciting high antibody titers and high virus-neutralizing antibody titers. By activating downstream signaling pathways of various pattern-recognition receptors, levamisole stimulated the expression of multiple cytokines and costimulatory molecules. Owing to these immunostimulatory effects, levamisole elicited host defense against viral infections in pigs. Our findings demonstrate the potential of levamisole as an immunostimulatory agent.DiscussionThe results also indicate that levamisole, as an adjuvant for animal vaccines, can elicit robust innate and adaptive immune responses, thereby enhancing host defense against viral infections. This study provides a promising approach for the development of improved FMD vaccine strategies in the future. |
format | Article |
id | doaj-art-9f3e54df492d4d9dbe34d0dae1170143 |
institution | Kabale University |
issn | 1664-302X |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Microbiology |
spelling | doaj-art-9f3e54df492d4d9dbe34d0dae11701432025-01-08T06:12:24ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-01-011510.3389/fmicb.2024.14935611493561Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responsesGang Sik KimDong Yun KwakHyeong Won KimSeokwon ShinMi-Kyeong KoSeong Yun HwangSo Hui ParkDong Hyeon KimJong-Hyeon ParkSu-Mi KimMin Ja LeeIntroductionAn effective vaccination policy must be implemented to prevent foot-and-mouth disease (FMD). However, the currently used vaccines for FMD have several limitations, including induction of humoral rather than cellular immune responses.MethodsTo overcome these shortcomings, we assessed the efficacy of levamisole, a small-molecule immunomodulator, as an adjuvant for the FMD vaccine. We conducted in vitro studies using murine peritoneal exudate cells (PECs) and porcine peripheral blood mononuclear cells (PBMCs) and in vivo studies using mice (experimental animals) and pigs (target animals). We evaluated levamisole-mediated modulation of the innate and adaptive immune responses; early, mid-term, and long-term immune-inducing effects; modes of action; and host defense against viral infection.ResultsLevamisole treatment promoted IFNγ secretion in murine PECs and porcine PBMCs. Additionally, it induced robust and long-lasting immune responses by eliciting high antibody titers and high virus-neutralizing antibody titers. By activating downstream signaling pathways of various pattern-recognition receptors, levamisole stimulated the expression of multiple cytokines and costimulatory molecules. Owing to these immunostimulatory effects, levamisole elicited host defense against viral infections in pigs. Our findings demonstrate the potential of levamisole as an immunostimulatory agent.DiscussionThe results also indicate that levamisole, as an adjuvant for animal vaccines, can elicit robust innate and adaptive immune responses, thereby enhancing host defense against viral infections. This study provides a promising approach for the development of improved FMD vaccine strategies in the future.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1493561/fulllevamisolevaccine adjuvanthost defenseimmunomodulationinnate and adaptive immunity |
spellingShingle | Gang Sik Kim Dong Yun Kwak Hyeong Won Kim Seokwon Shin Mi-Kyeong Ko Seong Yun Hwang So Hui Park Dong Hyeon Kim Jong-Hyeon Park Su-Mi Kim Min Ja Lee Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses Frontiers in Microbiology levamisole vaccine adjuvant host defense immunomodulation innate and adaptive immunity |
title | Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses |
title_full | Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses |
title_fullStr | Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses |
title_full_unstemmed | Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses |
title_short | Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses |
title_sort | levamisole as a viral vaccine adjuvant induces robust host defense through the modulation of innate and adaptive immune responses |
topic | levamisole vaccine adjuvant host defense immunomodulation innate and adaptive immunity |
url | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1493561/full |
work_keys_str_mv | AT gangsikkim levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT dongyunkwak levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT hyeongwonkim levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT seokwonshin levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT mikyeongko levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT seongyunhwang levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT sohuipark levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT donghyeonkim levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT jonghyeonpark levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT sumikim levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses AT minjalee levamisoleasaviralvaccineadjuvantinducesrobusthostdefensethroughthemodulationofinnateandadaptiveimmuneresponses |